Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 7, Status: Authorised

New product information wording: extracts from PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Date of authorisation: 30/06/2013, Revision: 26, Status: Authorised

Minutes - HMA-EMA joint Network Data Steering Group meeting - 15 April 2026

Combination Products Operational Group: agendas and highlight reports

Human medicines European public assessment report (EPAR): Kapruvia, difelikefalin, Date of authorisation: 25/04/2022, Revision: 5, Status: Authorised

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026